GlassScriptPhysician profile
Lori Lucas
NPI 1396070439
$5,646.95
in general payments reported to CMS, 2019-2025
55 companies · $866 in 2025
The $866 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $735 · 2022: $1,492 · 2023: $1,344 · 2024: $1,210 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,220 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,219.88 |
| Education | $199.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $884.30 | 2021-2025 | Tagrisso, Enhertu, Calquence |
| Daiichi Sankyo INC. | $349.11 | 2021-2025 | Enhertu, Datroway |
| Incyte Corporation | $327.14 | 2021-2025 | Jakafi |
| Gilead Sciences, INC. | $321.81 | 2021-2025 | Trodelvy |
| Beigene USA, INC. | $243.91 | 2022-2024 | Brukinsa |
| E.R. Squibb & Sons, L.L.C. | $222.96 | 2021-2025 | Opdivo |
| Bayer Healthcare Pharmaceuticals INC. | $196.38 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $193.42 | 2022-2025 | |
| Seagen INC. | $187.85 | 2021-2023 | Padcev |
| Janssen Biotech, INC. | $187.16 | 2021-2023 | Imbruvica, Darzalex, Tecvayli |
| Takeda Pharmaceuticals U.S.A., INC. | $173.07 | 2022-2025 | Fruzaqla, Ninlaro |
| Eisai INC. | $170.23 | 2021-2024 | |
| Medline Industries LP | $127.52 | 2024-2025 | |
| Astellas Pharma US INC | $124.72 | 2023-2025 | Xospata, Padcev, Vyloy |
| Celgene Corporation | $112.85 | 2021-2023 | Reblozyl, Pomalyst |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.